A story featured on Boston's NPR blog CommonHealth spotlights recent progress made in cystic fibrosis drug development.
The blog post focuses on new treatments developed by Vertex Pharmaceuticals Inc. in collaboration with the Cystic Fibrosis Foundation that target the underlying cause of CF, and highlights the recent
Also highlighted are recent positive results from a Phase 2 combination study of Kalydeco and VX-809. The combination therapy could potentially help 27-year-old Danny Bessette, who was featured on the cover of Science magazine when the CF
Read the full story.